Notice2023-18363
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 25, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Program Evaluation for PS22-2208 Component 2. This information collection request is designed to monitor and evaluate the PS22-2208 Component 2 funding opportunity's overall goal of supporting syringe services program (SSP) subrecipients in meeting the needs of people who use drugs (PWUD) and reducing infectious disease and other harms related to drug use during the 5- year PS22-2208 Cooperative Agreement.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 164 (Friday, August 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 164 (Friday, August 25, 2023)]
[Notices]
[Pages 58278-58280]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18363]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-23-23HS; Docket No. CDC-2023-0074]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Program Evaluation for PS22-2208
Component 2. This information collection request is designed to monitor
and evaluate the PS22-2208 Component 2 funding opportunity's overall
goal of supporting syringe services program (SSP) subrecipients in
meeting the needs of people who use drugs (PWUD) and reducing
infectious disease and other harms related to drug use during the 5-
year PS22-2208 Cooperative Agreement.
DATES: CDC must receive written comments on or before October 24, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0074 by either of the following methods:
[[Page 58279]]
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#cba4a6a98ba8afa8e5aca4bd"><span class="__cf_email__" data-cfemail="d8b7b5ba98bbbcbbf6bfb7ae">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Program Evaluation for PS22-2208 Component 2--New--National Center
for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
PS22-2208 Component 2 (Strengthening Syringe Services Programs)
serves as a coordinated and accountable mechanism for distribution of
funding to syringe services programs (SSPs) to support implementation
and expansion of services in areas of the United States, Territories,
and Tribal Nations disproportionately affected by infectious disease
consequences of injection drug use. Project activities will directly
contribute to establishing and expanding a national SSP infrastructure
and prevention of infectious disease consequences of drug use. CDC has
funded the National Alliance of State and Territorial AIDs Directors
(NASTAD) to implement this project. NASTAD, in partnership with
University of Washington will collect monitoring and evaluation data
from funded SSPs through their internal mechanisms, both for their
internal evaluation as well as to report semi-annual and annual project
performance reports and stratified aggregate data to CDC.
The primary purpose of this information collection is to monitor
and evaluate the PS22-2208 Component 2 funding opportunity's overall
goal of supporting SSP subrecipients in meeting the needs of people who
use drugs (PWUD) and reducing infectious disease and other harms
related to drug use. During the first year of this Cooperative
Agreement, all PS22-2208 SSP subrecipients will be sent a 25-minute
baseline program evaluation survey at the start of project
implementation, and a 15-minute quarterly program evaluation survey in
the following three quarters of the project period. For Years 2-5, new
PS22-2208 SSP subrecipients will be sent the baseline survey at the
start of project implementation, and all existing subrecipients will
receive the quarterly program evaluation survey in the following three
quarters of the project period. SSP subrecipients will primarily
complete the survey online in REDCap, with options to complete via
telephone or videoconferencing modalities. Subrecipients will be asked
to complete the surveys within one month of receipt and will receive
weekly reminders until the survey is completed. SSP subrecipients may
be reminded informally during meetings with NASTAD and may also work
with their NASTAD point-of-contact to determine an alternate method of
survey completion. The survey will include questions on operational and
programmatic characteristics, and quantity of prevention and treatment
services provided in-person, through tele-health, and through
navigation to off-site care, during the specified evaluation period.
Approximately 200 SSPs will participate in the survey. We estimate
that it will take 70 minutes to complete the baseline survey and three
quarterly surveys, regardless of how the respondent chooses to complete
it (i.e., self-administered online or NASTAD staff-administered by
phone or videoconferencing). CDC requests OMB approval for an estimated
233 annual burden hours. There is no cost to survey participants other
than their time.
Estimates of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent Form Number of responses per per response Total burden
respondents respondent (hours) (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs........ Strengthening 200 1 25/60 83
Syringe
Services
Programs
Baseline Survey.
All participating SSPs........ Strengthening 200 3 15/60 150
Syringe
Services
Programs
Quarterly
Survey.
---------------------------------------------------------------------------------
[[Page 58280]]
Total..................... ................ .............. .............. .............. 233
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-18363 Filed 8-24-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 25, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.